News About: Pharm. Industry
KFDA's rating policy to achieve industry quality improvement.
As a result of the successful KFDA's rating policy of the industry, the pharmaceutical industry created 152.6 billion won of the facility investment and 612 new jobs.
The KFDA improved the GMP level and thereby 20%...
Pure pharmaceutical firms totals 229
The number of pharmaceutical firms with good manufacturing practice (GMP) endorsement totaled 229 as of July 2006, according to Yakup Shinmoon.
By industry, companies manufacturing finished pharmaceuticals, bulk ...
Pfizer to seek drug study with KoreaPfizer Inc., a major U.S. pharmaceutical company, has said it intends to broaden joint research endeavors with Korean labs.
In a meeting with industry experts and the Korean ...
|
Pfizer Korea conducting 34 multinational trials
?事法施行規則
Pfizer Korea, a Korean unit of Pfizer Inc., announced that it is conducting a total of 34 multinational clinical trials in Korea, pointing to the rapid development of the local clinical experime...
Epochal sales record of Hanmi's Amodipin.Just in 2 years of its market launching of Amodipin developed by Hanmi as a modified new amlodipine derivative, it made an epochal record with the total 8.5 million prescription...
|
Daewoong running into anti-cancer drug markets
Daewoong announced the anti-cancer drug business projects on Aug. 9, covering that until 2010 the company targeted to get 100 billion won of sales from the anti-cancer drug markets by realizing 3 subjects, namely, a d...
Kwangdong Pharm to cash in on Vita 500 marketing
Kwangdong Pharm is looking to add excitement to Vita 500, Vitamin C drink, by patronizing sporting events with premium images in foreign countries and letting consumers see in the right environment.
The company spo...
Hanall Pharm stock benefits from anti-atopic medication patent
Shares of Hanall Pharm extended gains on expectations that its patent application of a novel anti-atopic drug will bring much profits in the long tem, analysts said on September 4.
Hanall closed 14.92 percent up at...
KPMA suggested special tax privileges for R&D to extend.
The Ministry of Finance and Economy earlier disclosed the revised draft of the special tax privilege act in advance, which restricted the pharmaceutical industry for the R&D investment and the new drug development by ...
Number of technical transfer tops 35
A total number of Korea's technical transfers reached 35 this year since Hanmi Pharm exported its improved ceftriaxone process to H. Hoffmann-La Roche of Switzerland in 1989, according to the Korea Development Researc...
